Wealth Enhancement & Preservation of GA »

Fs Global Cr Opportunitie Fda shares owned by Wealth Enhancement & Preservation of GA

Quarter-by-quarter ownership of Fs Global Cr Opportunitie Fda (FSCO) shares owned by Wealth Enhancement & Preservation of GA from 13F filings

Historical chart of Wealth Enhancement & Preservation of GA investment in Fs Global Cr Opportunitie Fda

Tip: Access up to 7 years of quarterly data

All positions including Fs Global Cr Opportunitie Fda held by Wealth Enhancement & Preservation of GA consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fs Global Cr Opportunitie Fda by Wealth Enhancement & Preservation of GA

Quarter filed Position value Share count Share price at filing
2023-06-30 $132k 28k 4.75
2023-03-31 $65k 15k 4.44

More positions owned by Wealth Enhancement & Preservation of GA

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
Invesco Exchange Traded Fd T S&p 500 Garp Etf (SPGP)
First Tr Exchange-traded Cap Strength Etf (FTCS)
Spdr Dow Jones Indl Average Ut Ser 1 (DIA)
Ishares Tr Core Us Aggbd Et (AGG)
First Tr Exchng Traded Fd Vi Tcw Opportunis (FIXD)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Ssga Active Etf Tr Blackstone Senr (SRLN)
Nucor Corporation (NUE)
Home Depot (HD)
Apple (AAPL)
Microsoft Corporation (MSFT)
Eli Lilly & Co. (LLY)

View all positions for Wealth Enhancement & Preservation of GA

Top funds holding Fs Global Cr Opportunitie Fda

Commonwealth Equity Services
Nomura Holdings
Cambridge Investment Research Advisors
Thomas J. Herzfeld Advisors
Sit Investment Associates
Wagner Wealth Management
Cetera Investment Advisers
LPL Financial
Penserra Capital Management
Envestnet Asset Management
H D Vest Advisory Services
Advisor Group Holdings
Rockefeller Capital Management
Saba Capital Management
Morgan Stanley

View all funds holding Fs Global Cr Opportunitie Fda